Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluzone High-Dose in Adults 50-64
NCT01258595Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2010
- Primary completion
- Mar 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of trivalent inactivated influenza vaccine high-dose in influenza, sponsored by Sanofi. Started Nov 2010; status: completed.
02
Drugs
trivalent inactivated influenza vaccine high-dose
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01258595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01258595.